Histamine phosphate structure
|
Common Name | Histamine phosphate | ||
---|---|---|---|---|
CAS Number | 51-74-1 | Molecular Weight | 307.14 | |
Density | N/A | Boiling Point | 887.3ºC at 760 mmHg | |
Molecular Formula | C5H15N3O8P2 | Melting Point | 128-132 °C | |
MSDS | Chinese USA | Flash Point | 490.4ºC | |
Symbol |
GHS05, GHS07, GHS08 |
Signal Word | Danger |
Use of Histamine phosphateHistamine diphosphate is a potent agonist of histamine receptors and vasodilator. It can activate nitric oxide synthetase. |
Name | histamine phosphate |
---|---|
Synonym | More Synonyms |
Description | Histamine diphosphate is a potent agonist of histamine receptors and vasodilator. It can activate nitric oxide synthetase. |
---|---|
Related Catalog | |
References |
Boiling Point | 887.3ºC at 760 mmHg |
---|---|
Melting Point | 128-132 °C |
Molecular Formula | C5H15N3O8P2 |
Molecular Weight | 307.14 |
Flash Point | 490.4ºC |
PSA | 142.27000 |
Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS05, GHS07, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H315-H317-H318-H334-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338-P342 + P311 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn |
Risk Phrases | 20/21/22-36/37/38-42/43-41-37/38-22 |
Safety Phrases | S26-S36-S45-S36/37/39-S22 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | NI5425000 |
HS Code | 2933290090 |
HS Code | 2933290090 |
---|---|
Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Development of a UHPLC-MS/MS method for the determination of plasma histamine in various mammalian species.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 971 , 35-42, (2014) Histamine is an important mediator of anaphylactic reactions. Although several methods have been developed to measure histamine levels, each has its limitations. In this study, we developed and valida... |
|
Validated capillary electrophoresis method for the assay of a range of basic drugs.
J. Pharm. Biomed. Anal. 13(8) , 951-7, (1995) A capillary electrophoresis method has been developed and validated for the analysis of a wide range of basic drugs. Acceptable precision was obtained by employing an internal standard. Optimal sensit... |
|
Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast.
Ann. Allergy Asthma Immunol. 86(1) , 44-50, (2001) The relative contribution of histamine and the cysteinyl leukotrienes to the early and late cutaneous allergic responses (ECAR and LCAR) can be studied using antagonists of these mediators.To determin... |
EINECS 200-118-4 |
2-(1H-Imidazol-5-yl)ethanamine phosphate (1:1) |
HISTAMINE DIHYDROGEN PHOSPHATE |
2-(1H-Imidazol-4-yl)ethanamine bis(phosphate) |
1H-Imidazole-5-ethanamine, phosphate (1:1) |
Histamine diphosphate monohydrate |
histamine acid phosphate |
Histamine Diphosphate Hydrate |
Histamine phosphate |
MFCD00064316 |